fbpx Skip to content


Two New Anti-Obesity Drugs Approved by FDA

| Earn 1 CEC - Take Quiz

In late June, the U.S. Food and Drug Administration approved a new prescription weight loss drug for the first time in 13 years. Lorcaserin—to be marketed in the U.S. under the name Belviq®—was approved as an addition to a reduced-calorie diet and exercise for chronic weight management, according to an FDA press release. On its heels in mid-July came a second approval—for Qsymia™—another prescription drug for weight loss.

“Belviq may offer a promising new and seemingly safer pharmacological option for individuals struggling with obesity,” said Cedric X. Bryant, PhD, chief science officer for the American Council on Exercise (ACE). “It must be remembered, however, that obesity is a complex problem requiring a multifaceted solution. For the best and most lasting results, physical activity, nutrition and behavior modification must be part of any treatment approach to obesity.”

Belviq is approved for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults who have a BMI of 27 or greater (overweight) and at least one weight-related condition, such as high blood pressure (hypertension), type 2 diabetesor high cholesterol (dyslipidemia). Belviq works by activating the serotonin 2C receptor in the brain. Activation of this receptor may help a person eat less and feel full after eating smaller amounts of food.

Specific details about Qsymia were not available at press time.

Bryant cautions that this is no panacea to overweight and obesity challenges. “Belviq should not be considered a weight loss cure-all or the answer to the nation’s obesity epidemic,” he said. “Patients must be armed with tools and information that will help them set realistic weight loss goals, follow a healthy diet and engage in safe and effective physical activity programs, regardless of fitness level, which will help increase their opportunity for living their most fit lives.”


Concerned about your place in the new fitness industry? We have 40 years of experience supporting pros just like you! Let’s create a new wellness paradigm together—IDEAfit+ is the extra edge you need. Once you team up with IDEA, be sure to take full advantage of all the benefits of membership.

Sandy Todd Webster

Sandy Todd Webster is the editor in chief of IDEA’s award-winning publications. She is Precision Nutrition Level 1 certified and is a Rouxbe Certified Plant-Based Professional cook.

When you buy something using the retail links in our content, we may earn a small commission. IDEA Health and Fitness Association does not accept money for editorial reviews. Read more about our Terms & Conditions and our Privacy Policy.


Subscribe to our Newsletter

Stay up tp date with our latest news and products.